Analytical Methods for Quantification of Vitamin D and Implications for Research and Clinical Practice

被引:35
作者
Stokes, Caroline S. [1 ]
Lammert, Frank [1 ]
Volmer, Dietrich A. [2 ]
机构
[1] Saarland Univ, Med Ctr, Dept Med 2, Homburg, Germany
[2] Saarland Univ, Inst Bioanalyt Chem, Saarbrucken, Germany
关键词
Epimer; 25-hydroxyvitamin D; mass spectrometry; standardisation; Vitamin D Standardisation Programme; STANDARDIZATION PROGRAM PROTOCOLS; 25-HYDROXYVITAMIN D DATA; LIQUID-CHROMATOGRAPHY; D DEFICIENCY; MASS-SPECTROMETRY; SERUM CONCENTRATIONS; D SUPPLEMENTATION; D-3; VARIABILITY; METABOLITES;
D O I
10.21873/anticanres.12332
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
A plethora of contradictory research surrounds vitamin D and its influence on health and disease. This may, in part, result from analytical difficulties with regard to measuring vitamin D metabolites in serum. Indeed, variation exists between analytical techniques and assays used for the determination of serum 25-hydroxyvitamin D. Research studies into the effects of vitamin D on clinical endpoints rely heavily on the accurate assessment of vitamin D status. This has important implications, as findings from vitamin D-related studies to date may potentially have been hampered by the quantification techniques used. Likewise, healthcare professionals are increasingly incorporating vitamin D testing and supplementation regimens into their practice, and measurement errors may be also confounding the clinical decisions. Importantly, the Vitamin D Standardisation Programme is an initiative that aims to standardise the measurement of vitamin D metabolites. Such a programme is anticipated to eliminate the inaccuracies surrounding vitamin D quantification.
引用
收藏
页码:1137 / 1144
页数:8
相关论文
共 64 条
[1]
Vitamin D: Deficiency, Sufficiency and Toxicity [J].
Alshahrani, Fahad ;
Aljohani, Naji .
NUTRIENTS, 2013, 5 (09) :3605-3616
[2]
[Anonymous], NED TIJDSCHR KLIN CH
[3]
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas [J].
Baron, John A. ;
Barry, Elizabeth L. ;
Mott, Leila A. ;
Rees, Judy R. ;
Sandler, Robert S. ;
Snover, Dale C. ;
Bostick, Roberd M. ;
Ivanova, Anastasia ;
Cole, Bernard F. ;
Ahnen, Dennis J. ;
Beck, Gerald J. ;
Bresalier, Robert S. ;
Burke, Carol A. ;
Church, Timothy R. ;
Cruz-Correa, Marcia ;
Figueiredo, Jane C. ;
Goodman, Michael ;
Kim, Adam S. ;
Robertson, Douglas J. ;
Rothstein, Richard ;
Shaukat, Aasma ;
Seabrook, March E. ;
Summers, Robert W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (16) :1519-1530
[4]
Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas A Randomized Clinical Trial [J].
Barry, Elizabeth L. ;
Peacock, Janet L. ;
Rees, Judy R. ;
Bostick, Roberd M. ;
Robertson, Douglas J. ;
Bresalier, Robert S. ;
Baron, John A. .
JAMA ONCOLOGY, 2017, 3 (05) :628-635
[5]
Vitamin D measurement standardization: The way out of the chaos [J].
Binkley, N. ;
Dawson-Hughes, B. ;
Durazo-Arvizu, R. ;
Thamm, M. ;
Tian, L. ;
Merkel, J. M. ;
Jones, J. C. ;
Carter, G. D. ;
Sempos, C. T. .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 173 :117-121
[6]
Analytical Bias in the Measurement of Serum 25-Hydroxyvitamin D Concentrations Impairs Assessment of Vitamin D Status in Clinical and Research Settings [J].
Black, Lucinda J. ;
Anderson, Denise ;
Clarke, Michael W. ;
Ponsonby, Anne-Louise ;
Lucas, Robyn M. .
PLOS ONE, 2015, 10 (08)
[7]
Proficiency testing of 25-Hydroxyvitamin D (25-OHD) assays [J].
Carter, G. D. ;
Berry, J. L. ;
Gunter, E. ;
Jones, G. ;
Jones, J. C. ;
Makin, H. L. J. ;
Sufi, S. ;
Wheeler, M. J. .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2010, 121 (1-2) :176-179
[8]
Measurement of vitamin D metabolites: an international perspective on methodology and clinical interpretation [J].
Carter, GD ;
Carter, CR ;
Gunter, E ;
Jones, J ;
Jones, G ;
Makin, HLJ ;
Sufi, S .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 89-90 (1-5) :467-471
[9]
25-Hydroxyvitamin D: A Difficult Analyte [J].
Carter, Graham D. .
CLINICAL CHEMISTRY, 2012, 58 (03) :486-488
[10]
Carter GD, 2011, CURR DRUG TARGETS, V12, P19